SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
Crossref DOI link: https://doi.org/10.1038/s41401-018-0198-0
Published Online: 2019-01-14
Published Print: 2019-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Chang-yong
Wang, Lei
Sun, Xing
Tang, Mi
Quan, Hai-tian
Zhang, Lian-shan
Lou, Li-guang
Gou, Shao-hua
Text and Data Mining valid from 2019-01-14
Article History
Received: 14 September 2018
Accepted: 22 November 2018
First Online: 14 January 2019